2.50
Hdl Handle:
http://hdl.handle.net/10755/156198
Type:
Presentation
Title:
Beta-Blocker Therapy and Symptom of Fatigue following Myocardial Infarction
Abstract:
Beta-Blocker Therapy and Symptom of Fatigue following Myocardial Infarction
Conference Sponsor:Sigma Theta Tau International
Conference Year:2008
Author:El Mokadem, Naglaa M., PhD, RN
P.I. Institution Name:Sultan Qaboos University
Title:Assistant Professor
[Research Paper or Poster Presentation] Background and Significant: Beta-blocker therapy after Myocardial Infarction (MI) reduces mortality and reverses cardiovascular remodeling. Despite the substantial benefits of beta-blockers after MI there are concerns about their association with symptom of fatigue. Fatigue has been reported as a problem in day-to-day recovery of patients with MI interfering with the enjoyment of life. However, the extent to which beta-blockers contributes to the severity and the change in the pattern of fatigue during the first six weeks after MI is unknown. Objectives: To examine the change in fatigue over time during the first six weeks of recovery after myocardial infarction (MI). Also, to determine to what extent do the dose of beta-blocker therapy contribute to the change in fatigue during the first six weeks after MI. Design: A prospective, descriptive repeated measures design was used. Sample: A convenience sample of 60 individual (mean age 54 years) with first time MI participated in the study. Methods: Investigator interviewed the subjects face-to-face three times: third day of admission and two and six weeks after discharge. Findings: Levels of fatigue significantly decreased over time. The main effect of time on fatigue was significant, F (1.7, 83.3) = 21.3, p < 0.00. Fatigue was moderately correlated with dose of beta-blockers therapy at time three, with subjects taking higher doses of beta-blocker therapy experiencing a higher level of fatigue. Conclusion: Findings of the study showed that fatigue was significantly declined during the early recovery period. Fatigue was moderately correlated with beta-blocker therapy. Implications: Developing practice guidelines and home-going discharge protocols should include specific approaches that take into account contextual factors. Treating at-risk patients with early interventions may be useful.
Repository Posting Date:
26-Oct-2011
Date of Publication:
17-Oct-2011
Sponsors:
Sigma Theta Tau International

Full metadata record

DC FieldValue Language
dc.typePresentationen_GB
dc.titleBeta-Blocker Therapy and Symptom of Fatigue following Myocardial Infarctionen_GB
dc.identifier.urihttp://hdl.handle.net/10755/156198-
dc.description.abstract<table><tr><td colspan="2" class="item-title">Beta-Blocker Therapy and Symptom of Fatigue following Myocardial Infarction</td></tr><tr class="item-sponsor"><td class="label">Conference Sponsor:</td><td class="value">Sigma Theta Tau International</td></tr><tr class="item-year"><td class="label">Conference Year:</td><td class="value">2008</td></tr><tr class="item-author"><td class="label">Author:</td><td class="value">El Mokadem, Naglaa M., PhD, RN</td></tr><tr class="item-institute"><td class="label">P.I. Institution Name:</td><td class="value">Sultan Qaboos University</td></tr><tr class="item-author-title"><td class="label">Title:</td><td class="value">Assistant Professor</td></tr><tr class="item-email"><td class="label">Email:</td><td class="value">naglaae@yahoo.com</td></tr><tr><td colspan="2" class="item-abstract">[Research Paper or Poster Presentation] Background and Significant: Beta-blocker therapy after Myocardial Infarction (MI) reduces mortality and reverses cardiovascular remodeling. Despite the substantial benefits of beta-blockers after MI there are concerns about their association with symptom of fatigue. Fatigue has been reported as a problem in day-to-day recovery of patients with MI interfering with the enjoyment of life. However, the extent to which beta-blockers contributes to the severity and the change in the pattern of fatigue during the first six weeks after MI is unknown. Objectives: To examine the change in fatigue over time during the first six weeks of recovery after myocardial infarction (MI). Also, to determine to what extent do the dose of beta-blocker therapy contribute to the change in fatigue during the first six weeks after MI. Design: A prospective, descriptive repeated measures design was used. Sample: A convenience sample of 60 individual (mean age 54 years) with first time MI participated in the study. Methods: Investigator interviewed the subjects face-to-face three times: third day of admission and two and six weeks after discharge. Findings: Levels of fatigue significantly decreased over time. The main effect of time on fatigue was significant, F (1.7, 83.3) = 21.3, p &lt; 0.00. Fatigue was moderately correlated with dose of beta-blockers therapy at time three, with subjects taking higher doses of beta-blocker therapy experiencing a higher level of fatigue. Conclusion: Findings of the study showed that fatigue was significantly declined during the early recovery period. Fatigue was moderately correlated with beta-blocker therapy. Implications: Developing practice guidelines and home-going discharge protocols should include specific approaches that take into account contextual factors. Treating at-risk patients with early interventions may be useful.</td></tr></table>en_GB
dc.date.available2011-10-26T14:33:01Z-
dc.date.issued2011-10-17en_GB
dc.date.accessioned2011-10-26T14:33:01Z-
dc.description.sponsorshipSigma Theta Tau Internationalen_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.